Headshot of Alexis M. Pinto, a member of the IAVI Board of Directors

Chief Legal Officer and Corporate Secretary, Zentalis Pharmaceuticals, Inc.

Alexis M. Pinto, J.D., is chief legal officer and corporate secretary at Zentalis Pharmaceuticals, where she is responsible for all legal and corporate governance matters. She is an accomplished legal and strategic executive with over two decades of deep experience in the health care industry.

Prior to joining Zentalis, Pinto served as corporate vice president and corporate secretary at Celgene Corporation, with broad responsibilities including business development, corporate governance and securities, executive compensation, and early research and development, and where she was lead counsel on critical transactions including the US$74B acquisition of Celgene by Bristol Myers Squibb. Prior to Celgene, Pinto was managing counsel at Merck & Co., where she led intricate transactions including the $14.2B sale of Merck Consumer Care to Bayer and the establishment of the India-based MSD/Wellcome Trust Hilleman Laboratories. Prior to joining Merck, Pinto was an associate at the law firm Paul, Hastings, Janofsky & Walker.

Pinto earned her J.D. from the University of Virginia School of Law and her B.A., magna cum laude, from the University of Virginia. She completed the corporate governance program at Columbia Business School and the leadership in corporate counsel program at Harvard Law School. Pinto is a member of the New York and the New Jersey state bars.